GS1 · UPSC Mains
India's domestic patent regime privileges public health over pharmaceutical industry's interests. Comment. (150 words)
| Topper | Rank | Source | Copy |
|---|---|---|---|
| Akshita Gupta | — | VisionIAS | p.17 |
| Jagrati Awasthi | — | VisionIAS | p.17 |
| Sai Manasa N C | — | VisionIAS | p.17 |
| Subhankar Bala | — | VisionIAS | p.17 |
| Gagan Singh Meena | — | VisionIAS | p.16 |
| Nisha | — | VisionIAS | p.17 |
| Ria Dabi | — | VisionIAS | p.17 |
| Ravindra Kumar Meena | — | VisionIAS | p.17 |
| H S Bhavana | — | VisionIAS | p.17 |
| Varuna Agrawal | — | VisionIAS | p.17 |
| Aishwarya Singh | — | VisionIAS | p.17 |
| Naman Goyal | — | VisionIAS | p.17 |
| Richa Kulkarni | — | VisionIAS | p.17 |
| Divyanshu Nigam | — | VisionIAS | p.17 |
| Roshan Meena | — | VisionIAS | p.17 |
| Kush Motwani | — | VisionIAS | p.16 |
| Jagrati Awasthi | — | UnlockIAS | p.17 |